Search Results - "Cain, Christopher F"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Total synthesis and chemical stability of pseudouridimycin by Cain, Christopher F, Scott, Aaron M, Sarnowski, Matthew P, Del Valle, Juan R

    “…We report the chemical synthesis of pseudouridimycin (1), an antimicrobial natural product that potently and selectively inhibits bacterial RNA polymerase…”
    Get more information
    Journal Article
  2. 2

    Synthesis of Enantiopure ε‑Oxapipecolic Acid by Howard, Evan H, Cain, Christopher F, Kang, Changwon, Del Valle, Juan R

    Published in Journal of organic chemistry (07-02-2020)
    “…A six-step synthesis of orthogonally protected (S)-ε-oxapipecolic acid is described, starting from a commercially available glutamate diester. The approach…”
    Get full text
    Journal Article
  3. 3

    Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues by Anwar, Avraz F., Cain, Christopher F., Garza, Michael J., Degen, David, Ebright, Richard H., Del Valle, Juan R.

    Published in ChemMedChem (02-01-2024)
    “…Pseudouridimycin (PUM) is a microbially produced C‐nucleoside dipeptide that selectively targets the nucleotide addition site of bacterial RNA polymerase…”
    Get full text
    Journal Article
  4. 4

    Front Cover: Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues (ChemMedChem 1/2024) by Anwar, Avraz F., Cain, Christopher F., Garza, Michael J., Degen, David, Ebright, Richard H., Del Valle, Juan R.

    Published in ChemMedChem (02-01-2024)
    “…The Front Cover shows a crystal structure of pseudouridimycin (PUM) bound to T. thermophilus RNA polymerase transcription complex. PUM′s inherent instability…”
    Get full text
    Journal Article
  5. 5

    Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy by Shao, Andong, Xu, Qin, Spalek, Walker T, Cain, Christopher F, Kang, Chang Won, Tang, Chih-Hang Anthony, Del Valle, Juan R, Hu, Chih-Chi Andrew

    Published in Molecular cancer therapeutics (01-12-2020)
    “…The IRE-1 kinase/RNase splices the mRNA of the XBP-1 gene, resulting in the spliced XBP-1 (XBP-1s) mRNA that encodes the functional XBP-1s transcription factor…”
    Get full text
    Journal Article
  6. 6

    IRE-1-Targeting Caged Prodrug with Endoplasmic Reticulum Stress-Inducing and XBP-1S-Inhibiting Activities for Cancer Therapy by Shao, Andong, Xu, Qin, Kang, Chang Won, Cain, Christopher F., Lee, Avery C., Tang, Chih-Hang Anthony, Del Valle, Juan R., Hu, Chih-Chi Andrew

    Published in Molecular pharmaceutics (04-04-2022)
    “…Activation of the IRE-1/XBP-1s pathway supports tumor progression. Here, we report a novel prodrug, TC-D-F07, in which a thiol-reactive dinitrobenzenesulfonyl…”
    Get full text
    Journal Article
  7. 7

    Structural Tailoring of a Novel Fluorescent IRE‑1 RNase Inhibitor to Precisely Control Its Activity by Shao, Andong, Kang, Chang Won, Tang, Chih-Hang Anthony, Cain, Christopher F, Xu, Qin, Phoumyvong, Claire M, Del Valle, Juan R, Hu, Chih-Chi Andrew

    Published in Journal of medicinal chemistry (13-06-2019)
    “…Activation of the IRE-1/XBP-1 pathway has been linked to many human diseases. We report a novel fluorescent tricyclic chromenone inhibitor, D-F07, in which we…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Synthesis of Biologically Relevant Compounds Harboring Unusual Hydroxamate or Proline Amino Acid Residues by Cain, Christopher F

    Published 01-01-2023
    “…Natural products are a rich source of structurally complex, medicinally potent compounds. In peptide natural products, this biological activity and complexity…”
    Get full text
    Dissertation